You are here

antibiotics

Nabriva shares leap higher on antibiotic trial success

Nabriva shares leap higher on antibiotic trial success

BioPharma Dive

Nabriva Therapeutics

clinical trials

Flag link:

Patients Not Always Informed of Study's Purpose in Noninferiority Trials

Patients Not Always Informed of Study's Purpose in Noninferiority Trials

RAPS.org

noninferiority trials

clinical trials

Flag link:

GSK puts old antibiotics and UK Horlicks business on the block

GSK puts old antibiotics and UK Horlicks business on the block

Yahoo/Reuters

Flag link:

Paratek goes 3-for-3 in PhIII, but antibiotic stumbles on side effect profile

Paratek goes 3-for-3 in PhIII, but antibiotic stumbles on side effect profile

Endpoints

clinical trials

Flag link:

People Are Not Petri Dishes--A New Study Shows Why Antibiotics Fail

People Are Not Petri Dishes--A New Study Shows Why Antibiotics Fail

Forbes

Flag link:

Several CEOs and 17 years later, Melinta scores an FDA OK for its antibiotic

Several CEOs and 17 years later, Melinta scores an FDA OK for its antibiotic

Endpoints

Melinta Therapeutics

Flag link:

In the hunt for new antibiotics, scientists hit pay dirt

In the hunt for new antibiotics, scientists hit pay dirt

Washington Post, DC

drug development

Flag link:

Johnson & Johnson’s $30B buyout suffers setback as Actelion antibiotic fails in one phase 3, succeeds in another

Johnson & Johnson’s $30B buyout suffers setback as Actelion antibiotic fails in one phase 3, succeeds in another

Fierce Biotech

clinical trials

Flag link:

Iterum bags $65M for phase 3 trial of ex-Pfizer antibiotic

Iterum bags $65M for phase 3 trial of ex-Pfizer antibiotic

Fierce Biotech

clinical trials

Flag link:

FDA’s Ruling on Generic ZITHROMAX 180-Day Exclusivity: A Little Something for Everyone!

FDA’s Ruling on Generic ZITHROMAX 180-Day Exclusivity: A Little Something for Everyone!

FDA Law Blog

Flag link:

Democrats Propose A $2B Prize Fund For New Antibiotics

Democrats Propose A $2B Prize Fund For New Antibiotics

Forbes

drug develoment

Improving Access to Affordable Prescription Drugs Act

Flag link:

Paratek Pharma shares surge 30% after antibiotic study results

Paratek Pharma shares surge 30% after antibiotic study results

Marketwatch

Flag link:

Google’s venture arm leads Spero’s $51.7M round for R&D work on a pipeline of new antibiotics

Google’s venture arm leads Spero’s $51.7M round for R&D work on a pipeline of new antibiotics

Endpoints

Google Ventures

Flag link:

Doctors Alarmed by Post-antibiotic Future

Doctors Alarmed by Post-antibiotic Future

VOA News

antibiotic resistance

drug development

Flag link:

A Nevada woman dies of a superbug resistant to every available antibiotic in the US

A Nevada woman dies of a superbug resistant to every available antibiotic in the US

Stat

antibiotic resistance

Flag link:

FDA says food livestock can no longer be fed medically important antibiotics

FDA says food livestock can no longer be fed medically important antibiotics

Stat

Flag link:

Faced with a dilemma, the FDA rejects Cempra’s antibiotic, demands big safety study

Faced with a dilemma, the FDA rejects Cempra’s antibiotic, demands big safety study

Endpoints

Flag link:

Will FDA approve a new antibiotic despite ‘significant’ safety issues?

Will FDA approve a new antibiotic despite ‘significant’ safety issues?

Stat/Pharmalot

Flag link:

FDA panel narrowly backs Cempra antibiotic

FDA panel narrowly backs Cempra antibiotic

Yahoo/AP

advisory panels

Flag link:

Cempra shares plummet ahead of FDA meeting on antibiotic

Cempra shares plummet ahead of FDA meeting on antibiotic

Yahoo/AP

Flag link: